Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TEVA · against 588 other Healthcare companies listed in US-listed
Ranked #146 of 589 · scores higher than 74% of peers
Bars: peers in each 10-point band of the valuation score59 peers with a valuation score of 50–59, including TEVA · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | TEVA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 1.4% | -4.3% | 70% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 6.9% | -0.8% | 79% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 2.8% | -2.2% | 70% | 20% | |
| Book yieldHigher is better · 587 reported | 15.9% | 24.9% | 36% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 247M USD | 98 | 80 | |
| 2 | 622M USD | 96 | 97 | |
| 2 | 441M USD | 96 | 81 | |
| 2 | 336M USD | 96 | 57 | |
| 2 | 817M USD | 96 | 69 | |
| 146 | 3.1B USD | 56 | 50 | |
| 146 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 57.0B USD |
| 56 |
| 47 |
| 146 | 3.1B USD | 56 | 35 |
| 146 | 33.4B USD | 56 | 63 |
| 146 | 48.8B USD | 56 | 54 |
| 152 | 2.0B USD | 55 | 51 |
| 152 | 994M USD | 55 | 55 |
| 152 | 467M USD | 55 | 46 |
| 152 | 3.0B USD | 55 | 39 |